Skip to main content
Top
Literature
1.
go back to reference Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, Katayama M, Yamamoto F, Yoshioka A (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68(4):236–240CrossRef Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, Katayama M, Yamamoto F, Yoshioka A (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68(4):236–240CrossRef
2.
go back to reference Alharbi A, Hassan SB, Al-Momen AK, Al-Saleh K, Nasr R, Kohgear H, Owaidah T (2018) Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors. Blood Coagul Fibrinolysis 29(2):211–215CrossRef Alharbi A, Hassan SB, Al-Momen AK, Al-Saleh K, Nasr R, Kohgear H, Owaidah T (2018) Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors. Blood Coagul Fibrinolysis 29(2):211–215CrossRef
3.
go back to reference Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, Evatt B (2003) Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 1(10):2191–2197CrossRef Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, Evatt B (2003) Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 1(10):2191–2197CrossRef
4.
go back to reference Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A (2008) A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 111(7):3540–3545CrossRef Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A (2008) A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 111(7):3540–3545CrossRef
5.
go back to reference Bowen DJ (2003) An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 1(1):33–40CrossRef Bowen DJ (2003) An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 1(1):33–40CrossRef
Metadata
Title
Influence of ABO Blood Group on von Willebrand Factor Antigen Level in Normal Individuals: A Cross-Sectional Study from Southern India
Authors
Pagadalu Lokababu Ambika
Rakhee Kar
Debdatta Basu
Rajendra Gurunath Kulkarni
Publication date
01-07-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01365-x

Other articles of this Issue 3/2021

Indian Journal of Hematology and Blood Transfusion 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine